Session Chair Profile
Anil Sethi lost his little sister Tania on 9/11/17 to metastatic breast cancer. From “oh my God don’t let it be cancer” to Tania’s last wishes, he’s experienced the caregiver journey, firsthand. In honor of Tania, Anil recently founded his sixth consumer-health venture, Ciitizen. To help kill cancer, in our lifetime. In 2016 Apple acquired Sethi’s consumer health startup Gliimpse which helped patients manage their health records. He also founded Sequoia, shepherding it through three venture rounds and in 2000 completing an IPO (Nasdaq: SQSW) before Sequoia’s sale to Citrix in 2001 for its patient-portal business. In 2004, WebMD (Nasdaq: WBMD) acquired Sethi’s first startup, Dakota Imaging, for its healthcare claims processing business.
A Patient-mediated mHealth Solution to Legally Collecting and Sharing Clinical Data
Physicist Max Planck suggested, “in the correct formulation of the question lies the key to the ‘correct’ answer.” The healthcare industry continues their slog in trying to control siloed patient data. They continue to ask incorrect questions and thus miss the key that connects better outcomes with lower costs—the patient. We’ll discuss the specifics of a model of patient mediated data collection and sharing, and how patients may be the key to accelerating and unlocking genomic data for curative discoveries.
Session Abstract – PMWC 2018 Silicon Valley
Session Synopsis: It’s fine to talk about cutting edge immunotherapy, biomarkers for early detection of disease, and the implications of ‘big data.’ But the dirty little secret surrounding big-data in healthcare is…we’ve got to think much smaller. Small data, N-of-1, the individual. Collected patient by patient, seven billion times over. Combining the power of people – and their health data – with developments in computational biology and technology for the knock-out punch on cancer. This session addresses patient data access, self-reported data, and regulatory solutions serving both human and AI/ML computational needs. We’ll outline a different way of thinking about the future – an attack on cancer that empowers people, patients and professionals.